For Lawyers | Log In | Join | Upload

Home
Legal News
- Business Law
- General Business
- Finance & Banking
- Intellectual Property
- Labor & Employment
- Real Estate - Commercial
- See All Subjects »
- Personal Law
- Criminal Law
- Estate Planning
- Family Law
- Personal Injury
- Worker's Compensation
- See All Subjects »
- Government Law
- Elections & Politics
- Military Law
- Government Contracting
- Administrative Law
- Civil Procedure
- See All Subjects »

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Personal Injury › Products Liability › Communications & Media Law

Read Personal Injury Law updates, news, and legal commentary from leading lawyers and law firms:

News & Analysis as of May 24, 2013

Carlton Fields

First Circuit Vacates Denial Of Class Certification In Opinion Concerning Pfizer’s Off-Label Marketing Of Neurontin

by Jennifer M. McPheeters | Carlton Fields on 5/7/2013

In Harden Manufacturing Co. v. Pfizer, Inc., 712 F.3d 60 (1st Cir. 2013), one of three cases addressing Pfizer’s off-label marketing of the anticonvulsant drug, Neurontin, the First Circuit vacated the district court’s denial...more

Lawyers.com

Monster Energy Offers Caffeine Math in Response to Report

by Michele Bowman | Lawyers.com on 1/23/2013

Aready under the microscope in a lawsuit filed by the parents of a teen who died after drinking two cans of its energy drink, Monster Beverage Corporation is taking a report by the Drug Abuse Warning Network (DAWN)...more

Sedgwick LLP

Generic Drug Law Update -- November 2012: An Agency "Warning Letter" Does Not a Lawsuit Make: Sometimes a "Warning Letter" Is...

by Carol Brophy | Sedgwick LLP on 11/14/2012

The number of consumer class action complaints brought against product manufacturers under state consumer protection and/or false advertising law statutes continues to rise. This increase can be traced in part to some...more

Lawyers.com

Lawsuits: Risperdal Schizophrenia Drug Makes Boys Grow Breasts

by Lawyers.com on 10/2/2012

The manufacturer of the antipsychotic drug Risperdal owes hundreds of millions of dollars to various states for improperly marketing the drug and encouraging doctors to prescribe it for ailments it was not approved for. The...more

Lawyers.com

Abbott Labs to Pay $1.5 Billion in Depakote Settlement

by Lawyers.com on 5/9/2012

Abbott Laboratories Inc. pleaded guilty and agreed to pay a $1.5 billion settlement for the company’s off-label promotion of anti-seizure drug Depakote. Depakote may be used only for epileptic seizures, bipolar mania and...more

Demas Law Group

Five Fingers, No Brains

by Demas Law Group on 5/4/2012

The recently filed suit against Vibram, maker of the Five Fingered Barefoot Running Shoe, alleges misrepresentation of the shoe’s benefits to runners. This headline piqued my interest as a lawyer, as a runner, and as an owner...more

Dechert LLP

Dismissal of Actimmune Proposed Class Action Affirmed

by Dechert LLP on 1/11/2012

The Ninth Circuit late last month upheld the dismissal of a proposed class action concerning alleged off-label marketing of the drug Actimmune. In re: Actimmune Marketing Litigation, Nos. 10-17237 and 10-17239 (9th Cir....more

GJEL Accident Attorneys

Reviewing the Legal Reviewers

by GJEL Accident Attorneys on 3/22/2011

Thanks to the rise of internet prominence, consumers have changed the way they look for attorneys. While they used to turn to attorneys they already know and look in the Yellow Pages, consumers are now going to Google and...more

8 Results

WORKING...

| Page: of 1 | WORKING...

WORKING...

View per page